Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Fertil Steril ; 91(1): 201-6, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18243177

RESUMO

OBJECTIVE: Our study evaluates the symptoms commonly attributed to adenomyosis in women undergoing the menopausal transition. We hypothesized that adenomyosis is more commonly seen in women with fibroids, pelvic pain, abnormal uterine bleeding, and in the presence of endometriosis. DESIGN: Retrospective cohort. SETTING: Multisite community-based study. PATIENT(S): Enrollees in the Study of Women's Health Across the Nation who had hysterectomies. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Relationship of adenomyosis to presenting symptoms and other patient characteristics. RESULT(S): Adenomyosis was found in 48% of 137 patients. Frequencies of presenting symptoms were similar in those with and without evidence of adenomyosis. The same prevalence of fibroids was seen in the presence or absence of adenomyosis: 37% versus 43%, endometriosis, 3% versus 5%, abnormal bleeding, 27% versus 33%, or chronic pelvic pain in the presence of fibroids 12% versus 17%. CONCLUSION(S): Adenomyosis is a common diagnosis seen in hysterectomized specimens from women undergoing the perimenopausal transition. Adenomyosis is equally common in women who also have fibroids, endometriosis, pelvic pain, or abnormal uterine bleeding, and women who do not. Therefore, adenomyosis is an incidental finding, not the source of the symptomatology. It appears not to be a "disease" per se but rather a normal variant.


Assuntos
Endometriose/genética , Variação Genética , Histerectomia , Perimenopausa , Escolaridade , Endometriose/epidemiologia , Endometriose/fisiopatologia , Endometriose/cirurgia , Feminino , Humanos , Consentimento Livre e Esclarecido , Prontuários Médicos , Miométrio/patologia , Miométrio/fisiopatologia , Prevalência , Grupos Raciais
2.
Am J Obstet Gynecol ; 198(3): 268.e1-6, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18191796

RESUMO

OBJECTIVE: The objective of the study was to evaluate whether lactation duration is associated with lower prevalence of metabolic syndrome (MetSyn) in midlife, parous women. STUDY DESIGN: This was a cross-sectional cohort analysis of 2516 parous, midlife women using multivariable logistic regression to determine the independent association of lactation and lactation duration on prevalence of MetSyn. RESULTS: One thousand six hundred twenty women (64.4%) reported a history of breast-feeding, with average lifetime duration of lactation of 1.16 (+/- 1.04) years. MetSyn was present in 536 women (21.3%). Adjusting for age, smoking history, parity, ethnicity, socioeconomic status, study site, physical activity, caloric intake, and high school body mass index, women with prior lactation had significantly lower odds of MetSyn (odds ratio [OR] 0.79, 95% confidence interval [CI] 0.63 to 0.99). Furthermore, increasing duration of lactation was similarly associated with lower odds of MetSyn (OR 0.88, 95% CI 0.77 to 0.99). CONCLUSION: Duration of lactation is associated with lower prevalence of MetSyn in a dose-response manner in midlife, parous women.


Assuntos
Lactação , Síndrome Metabólica/epidemiologia , Fatores Etários , Estudos de Coortes , Estudos Transversais , Feminino , Humanos , Síndrome Metabólica/prevenção & controle , Pessoa de Meia-Idade , Prevalência , Fatores de Tempo
3.
Womens Health Issues ; 15(4): 179-86, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16051109

RESUMO

BACKGROUND: Hysterectomy for a benign condition is common, particularly in the underserved. The objective was to determine if ethnic differences could be explained by known risk factors. METHODS: A phone survey was conducted at random on 15,160 women, ages 40-55, from seven US cities. Subjects were 49.9% Caucasian, 28.1% African American, 12.3% Hispanic, and 9.8% Asian American. RESULTS: Ethnicity was associated with past hysterectomy (odds ratio [OR]: Caucasian = 1.0, African American = 1.66; confidence interval [CI] = 1.46-1.88, Hispanic = 1.64, CI = 1.29-2.07; Asian American = 0.44, CI = 0.34-0.56), after adjustment for age, education, fibroids, body mass index, marital status, smoking, geographic site, and country of education. CONCLUSION: Because the highest rates occurred in the disadvantaged African American and Hispanic subgroups, and could not be explained by known risk factors, disparity in the form of overuse in these disadvantaged groups may exist.


Assuntos
Mau Uso de Serviços de Saúde/estatística & dados numéricos , Histerectomia/estatística & dados numéricos , Menopausa/etnologia , Grupos Minoritários/estatística & dados numéricos , Doenças Uterinas/etnologia , Doenças Uterinas/cirurgia , Populações Vulneráveis/etnologia , Adulto , Negro ou Afro-Americano/estatística & dados numéricos , Asiático/estatística & dados numéricos , Demografia , Feminino , Hispânico ou Latino/estatística & dados numéricos , Humanos , Histerectomia/psicologia , Entrevistas como Assunto , Pessoa de Meia-Idade , Razão de Chances , Fatores Socioeconômicos , Estados Unidos , População Branca/estatística & dados numéricos , Saúde da Mulher/etnologia
4.
J Clin Endocrinol Metab ; 89(6): 2622-31, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15181033

RESUMO

The dynamics of reproductive hormones that characterize the menopausal transition (perimenopause) are incompletely understood, particularly in non-Caucasian women. The Study of Women's Health across the Nation (SWAN) is a multiethnic cohort study of 3302 women at seven sites who were aged 42-52 yr at baseline. All participants are seen annually to assess a variety of endpoints. A subcohort of 848 women undergoes further investigation of their daily patterns of reproductive hormones in the Daily Hormone Study (DHS). DHS enrollees annually complete a daily collection of first morning voided urine for an entire menstrual cycle or up to 50 d (whichever comes first). Chemiluminescent assays measured urinary LH and FSH, as well as metabolites of estradiol [estrone conjugates (E1c)] and progesterone [pregnanediol glucuronide (Pdg)]. Cycles were assessed for evidence of luteal activity and day of luteal transition using previously developed algorithms. Midreproductive-aged women who underwent similar daily urinary analyses served as historical controls. Correlates of cycle features were identified. Eight hundred thirty-three cycles were evaluable and had complete data on covariates. Six hundred seventy-four (80.9%) cycles had evidence of luteal activity, and 159 (19.1%) did not. Women who were at least 49 yr old were less likely to have cycles with luteal activity and had more variable cycle length, higher total-cycle FSH, and lower total-cycle Pdg. Compared with heavier women, those with body mass index less than 25 kg/m2 had shorter cycles and higher total-cycle LH, FSH, and Pdg but not E1c. Chinese- and Japanese-American women had overall lower adjusted total-cycle E1c excretion. Smoking was not significantly associated with cycle length or hormones. When compared with cycles of younger control women, the cycles of the SWAN DHS participants had higher gonadotropins, lower total integrated Pdg, and E1c levels that were not different, which suggests that the ovary retains sensitivity to elevated FSH in the early menopausal transition. In this cross-sectional study of women over age 42 who are premenopausal or in the early menopausal transition, there were important differences in the characteristics of cycles related to age, body mass index, and ethnicity. Comparisons to younger women indirectly support the inhibin hypothesis, which proposes that the initiating event in the menopausal transition is the loss of inhibin negative feedback on FSH secondary to a diminished follicular reserve.


Assuntos
Menopausa/etnologia , Menopausa/fisiologia , Ciclo Menstrual/etnologia , Ciclo Menstrual/fisiologia , Adulto , Distribuição por Idade , Povo Asiático , População Negra , Constituição Corporal , Estudos de Coortes , Corpo Lúteo/fisiologia , Estrona/urina , Feminino , Hormônio Foliculoestimulante/urina , Humanos , Estudos Longitudinais , Hormônio Luteinizante/urina , Pessoa de Meia-Idade , Pregnanodiol/urina , Estados Unidos/epidemiologia , População Branca , Saúde da Mulher
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA